- Home
- PRTC vs AVNS Comparison
PRTC vs AVNS Comparison
Compare PRTC & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTC
- AVNS
- Stock Information
- Founded
- PRTC 2015
- AVNS 2014
- Country
- PRTC United States
- AVNS United States
- Employees
- PRTC N/A
- AVNS N/A
- Industry
- PRTC Biotechnology: Pharmaceutical Preparations
- AVNS Industrial Specialties
- Sector
- PRTC Health Care
- AVNS Health Care
- Exchange
- PRTC Nasdaq
- AVNS Nasdaq
- Market Cap
- PRTC 435.0M
- AVNS 522.0M
- IPO Year
- PRTC N/A
- AVNS N/A
- Fundamental
- Price
- PRTC $17.26
- AVNS $11.46
- Analyst Decision
- PRTC
- AVNS
- Analyst Count
- PRTC 0
- AVNS 0
- Target Price
- PRTC N/A
- AVNS N/A
- AVG Volume (30 Days)
- PRTC 3.7K
- AVNS 601.9K
- Earning Date
- PRTC 08-28-2025
- AVNS 10-31-2025
- Dividend Yield
- PRTC N/A
- AVNS N/A
- EPS Growth
- PRTC N/A
- AVNS N/A
- EPS
- PRTC 0.20
- AVNS N/A
- Revenue
- PRTC $6,391,000.00
- AVNS $692,500,000.00
- Revenue This Year
- PRTC N/A
- AVNS $0.25
- Revenue Next Year
- PRTC N/A
- AVNS $1.33
- P/E Ratio
- PRTC $8.54
- AVNS N/A
- Revenue Growth
- PRTC 1265.60
- AVNS 1.48
- 52 Week Low
- PRTC $13.30
- AVNS $9.30
- 52 Week High
- PRTC $24.99
- AVNS $23.68
- Technical
- Relative Strength Index (RSI)
- PRTC 46.41
- AVNS 49.57
- Support Level
- PRTC $17.63
- AVNS $10.66
- Resistance Level
- PRTC $18.17
- AVNS $12.00
- Average True Range (ATR)
- PRTC 0.21
- AVNS 0.38
- MACD
- PRTC -0.07
- AVNS -0.00
- Stochastic Oscillator
- PRTC 15.66
- AVNS 60.95
About PRTC PureTech Health plc
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.